Biomarkers in Gastrointestinal Cancer: Expert Perspectives and Guidance for Individualized Treatment

Download All
Get expert recommendations on using biomarker testing to individualize treatment for patients with gastrointestinal malignancies with an on-demand webcast, downloadable slideset, and expert commentary.
John L. Marshall, MD
Michael J. Pishvaian, MD, PhD
Manish A. Shah, MD

ClinicalThought

In this commentary, experts answer audience questions from a live satellite symposium presented at ASCO 2022 on the role of biomarker testing in gastrointestinal cancers and review novel targeted agents and approaches for patients with metastatic disease.

John L. Marshall, MD Michael J. Pishvaian, MD, PhD Manish A. Shah, MD Released: August 22, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Daiichi Sankyo, Inc.
Seagen Inc.
Turning Point Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings